196 related articles for article (PubMed ID: 36362325)
1. A Systematic Review and Meta-Analysis of Advanced Biomarkers for Predicting Incident Cardiovascular Disease among Asymptomatic Middle-Aged Adults.
Romero-Cabrera JL; Ankeny J; Fernández-Montero A; Kales SN; Smith DL
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362325
[TBL] [Abstract][Full Text] [Related]
2. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial.
Harutyunyan MJ; Mathiasen AB; Winkel P; Gøtze JP; Hansen JF; Hildebrandt P; Jensen GB; Hilden J; Jespersen CM; Kjøller E; Kolmos HJ; Gluud C; Kastrup J;
Scand J Clin Lab Invest; 2011 Feb; 71(1):52-62. PubMed ID: 21108561
[TBL] [Abstract][Full Text] [Related]
3. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
Skoglund PH; Arpegård J; Ostergren J; Svensson P
Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
[TBL] [Abstract][Full Text] [Related]
4. Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: Atherosclerosis Risk in Communities study.
Jia X; Buckley L; Sun C; Al Rifai M; Yu B; Nambi V; Virani SS; Selvin E; Matsushita K; Hoogeveen RC; Coresh J; Shah AM; Ballantyne CM
Eur J Prev Cardiol; 2023 Nov; 30(16):1731-1740. PubMed ID: 37306504
[TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
[TBL] [Abstract][Full Text] [Related]
6. Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study.
Ishigami J; Hoogeveen RC; Ballantyne CM; Folsom AR; Coresh J; Selvin E; Matsushita K
Am J Epidemiol; 2019 Dec; 188(12):2146-2155. PubMed ID: 31063194
[TBL] [Abstract][Full Text] [Related]
7. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
Ahluwalia N; Blacher J; Szabo de Edelenyi F; Faure P; Julia C; Hercberg S; Galan P
Atherosclerosis; 2013 Jun; 228(2):478-84. PubMed ID: 23582589
[TBL] [Abstract][Full Text] [Related]
9. Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality.
Oluleye OW; Folsom AR; Nambi V; Lutsey PL; Ballantyne CM;
Ann Epidemiol; 2013 Feb; 23(2):66-73. PubMed ID: 23228375
[TBL] [Abstract][Full Text] [Related]
10. Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).
Daniels LB; Clopton P; deFilippi CR; Sanchez OA; Bahrami H; Lima JA; Tracy RP; Siscovick D; Bertoni AG; Greenland P; Cushman M; Maisel AS; Criqui MH
Am Heart J; 2015 Dec; 170(6):1170-83. PubMed ID: 26678639
[TBL] [Abstract][Full Text] [Related]
11. Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease.
Peer A; Falkensammer G; Alber H; Kroiss A; Griesmacher A; Ulmer H; Pachinger O; Mair J
Heart; 2009 Feb; 95(4):297-303. PubMed ID: 18708421
[TBL] [Abstract][Full Text] [Related]
12. Subclinical cardiovascular disease and frailty risk: the atherosclerosis risk in communities study.
Jia Y; Li D; Yu J; Liu Y; Li F; Li W; Zhang Q; Gao Y; Zhang W; Zeng Z; Zeng R; Liao X; Zhao Q; Wan Z
BMC Geriatr; 2022 Apr; 22(1):321. PubMed ID: 35413794
[TBL] [Abstract][Full Text] [Related]
13. NT-proBNP best predictor of cardiovascular events and cardiovascular mortality in secondary prevention in very old age: the Leiden 85-plus Study.
van Peet PG; Drewes YM; de Craen AJ; Gussekloo J; de Ruijter W
PLoS One; 2013; 8(11):e81400. PubMed ID: 24278434
[TBL] [Abstract][Full Text] [Related]
14. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
Pareek M
Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study.
Shlipak MG; Ix JH; Bibbins-Domingo K; Lin F; Whooley MA
Am J Med; 2008 Jan; 121(1):50-7. PubMed ID: 18187073
[TBL] [Abstract][Full Text] [Related]
16. Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study.
Daniels LB; Barrett-Connor E; Clopton P; Laughlin GA; Ix JH; Maisel AS
J Am Coll Cardiol; 2012 Mar; 59(12):1101-9. PubMed ID: 22421304
[TBL] [Abstract][Full Text] [Related]
17. N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease.
Ndrepepa G; Kastrati A; Braun S; Mehilli J; Niemöller K; von Beckerath N; von Beckerath O; Vogt W; Schömig A
Am J Med; 2006 Apr; 119(4):355.e1-8. PubMed ID: 16564781
[TBL] [Abstract][Full Text] [Related]
18. Circulating biomarkers for long-term cardiovascular risk stratification in apparently healthy individuals from the MONICA 10 cohort.
Frary CE; Blicher MK; Olesen TB; Stidsen JV; Greve SV; Vishram-Nielsen JK; Rasmussen SL; Olsen MH; Pareek M
Eur J Prev Cardiol; 2020 Apr; 27(6):570-578. PubMed ID: 31718257
[TBL] [Abstract][Full Text] [Related]
19. CXCL9 and NT-proBNP, a notable link between inflammatory mediator and cardiovascular disease biomarker in rheumatoid arthritis.
Shamsi A; Roghani SA; Soufivand P; Pournazari M; Khoobbakht F; Bahrehmand F; Taghadosi M
Clin Rheumatol; 2024 Jan; 43(1):137-145. PubMed ID: 38006573
[TBL] [Abstract][Full Text] [Related]
20. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
